Moderna’s Israeli medical exec ‘awed’ by vaccine results

He began his career in the genetics research group at pharma giant GlaxoSmithKline, where he built the oncology translational medicine team and led translational research on oral cancer drug lapatinib. He also sits on the board of Adaptimmune Therapeutics. Prior to joining Moderna in Cambridge, Massachusetts, Zaks was senior vice president responsible for oncology drug … Continue reading Moderna’s Israeli medical exec ‘awed’ by vaccine results